Belarus

Keywords: Tuberculosis

Activities  2015 International Activity Report

In 2015, MSF opened its first project in Belarus, where the incidence of drug-resistant tuberculosis (DR-TB) is extremely high. Over half of Belorussian TB patients are considered to have multidrug-resistant TB.

MSF is supporting the Ministry of Health in three TB dispensaries in the capital Minsk, and is working in a nearby hospitalisation centre in Volkovichi, with the main aim of improving outpatient DR-TB treatment. MSF also provides counselling and socio-economic support for patients, and is using new drugs to treat people with extensively drug-resistant TB.

More than 100 TB patients received pre-treatment diagnosis, treatment with regular follow up counselling sessions, and social support (food) in order to improve their adherence. MSF also provided treatment using new drugs (bedaquiline and delamanid) for 12 patients with extremely drug-resistant TB.

 Year MSF first worked in the country: 2015

Activity Reports